Literature DB >> 30266123

Squamous Cell Carcinoma of the Breast.

Sohail Saqib Chatha1, Razia Bano2, Maham Farooq3, Mahwish Farooq4, Umar Farooq2, Abdullah Zakaullah2.   

Abstract

OBJECTIVE: To analyse the epidemiological characteristics, clinical presentations, and histopathological as well as immunological characteristics of squamous cell carcinoma (SCC) of breast. STUDY
DESIGN: A descriptive study. PLACE AND DURATION OF STUDY: Combined Military Hospital, Rawalpindi, from January 1997 to January 2017.
METHODOLOGY: Data of all patients, diagnosed as squamous cell carcinoma of breast over defined period of time, were collected and analysed with respect to their clinical presentation, histopathology and receptor status. Year-wise cases of SCC of breast were separated.
RESULTS: Thirty patients, diagnosed as squamous cell carcinoma of breast, were identified over a period of 20 years. There was an increase in number of cases diagnosed after 2007 as compared to before 2007. Moreover, 12 (40%) cases were hormonereceptor positive while 18 (60%) were of unknown status. Out of the total, 10 (33%) cases were well differentiated, 17 (57%)were moderately differentiated, while 3 (10%) were poorly differentiated. Seventeen (57%) cases presented as breast masses, 10 (33%) had skin ulceration in addition to breast mass, while 3 (10%) cases presented as fungating masses along with chest wall involvement.
CONCLUSION: There is an increased incidence of SCC of breast which can be due to better diagnostic facilities and more awareness amongst doctors about different varieties of breast cancers and their impact on the prognosis of disease.

Entities:  

Mesh:

Year:  2018        PMID: 30266123     DOI: 3020

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  2 in total

1.  Clinicopathological and therapeutic analysis of primary breast squamous cell carcinoma.

Authors:  Zhiying Chen; Ning An; Lei Zhang; Huanliang Cui; Yuqi Jiang; Yongchun Zhang
Journal:  Gland Surg       Date:  2022-01

2.  Significant efficacy of paclitaxel plus carboplatin (TP) as a neoadjuvant regimen for metaplastic squamous cell carcinoma of the breast: a rare case report and literature review.

Authors:  Baolin Chen; Yan Jiang; Chengmin Luo; Yuxiang Bao; Na Tan; Taolang Li; Xiaoming Cheng; Junyuan Lv
Journal:  Transl Cancer Res       Date:  2022-08       Impact factor: 0.496

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.